A. Deana

发表

Lost in translation: the influence of ribosomes on bacterial mRNA decay.

J. Belasco, A. Deana, 2005, Genes & development.

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives.

B. E. Evans, W. F. Hoffman, A. Deana, 1985, Journal of Medicinal Chemistry.

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives.

W. F. Hoffman, P. Anderson, J. Hirshfield, 1986, Journal of Medicinal Chemistry.

2-(AMINOMETHYL)PHENOLS, A NEW CLASS OF SALURETIC AGENTS. 5. FUSED-RING ANALOGS

A. Deana, Robert L. Smith, G. Stokker, 1983 .

2-(Aminomethyl)phenols, a new class of saluretic agents. 5. Fused-ring analogues.

A. Deana, R. Smith, G. Stokker, 1983, Journal of medicinal chemistry.

2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution

A. Deana, C. Sweet, Robert L. Smith, 1981 .

2-(Aminomethyl)phenols, a new class of saluretic agents. 3. Effects of functional group reorientation and modification.

A. Deana, G. Stokker, E. Cragoe, 1981, Journal of Medicinal Chemistry.

2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution.

A. Deana, C. Sweet, G. Stokker, 1980, Journal of medicinal chemistry.

Inhibitors of gastric acid secretion: antisecretory 2-pyridylurea derivatives.

C. N. Habecker, A. Deana, R. Hirschmann, 1983, Journal of medicinal chemistry.

Condensed Cyclobutane Aromatic Compounds. VIII. The Mechanism of Formation of 1,2-Dibromobenzocyclobutene; A New Diels-Alder Synthesis

A. Deana, M. Cava, K. Muth, 1959 .

2-(Aminomethyl)phenols, a new class of saluretic agents. 4. Effects of oxygen and/or nitrogen substitution.

A. Deana, G. Stokker, E. Cragoe, 1982, Journal of medicinal chemistry.

Condensed Cyclobutane Aromatic Compounds. XI. Benzo[1,2:4,5]dicyclobutene

A. Deana, M. Cava, K. Muth, 1960 .

Condensed Cyclobutane Aromatic Compounds. XIII. An Attempted Synthesis of 1,2-Diphenylbenzocyclobutene

A. Deana, M. Cava, M. Mitchell, 1960 .

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones.

A. Deana, A. Alberts, J. Huff, 1990, Journal of medicinal chemistry.

Synthesis and utilization of the chiral synthon methyl 3-O-benzyl-2,4,6-trideoxy-6-iodo-.alpha.-D-erythro-hexopyranoside in the synthesis of a potent HMG-CoA reductase inhibitor

A. Deana, C. Rooney, J. D. Prugh, 1986 .

Utilization of the chiral synthon, methyl 3-O-benzyl-2,4,6-trideoxy-6-iodo-α-D-erythro-hexopyranoside in the synthesis of a potent HMG-CoA reductase inhibitor

A. Deana, C. Rooney, J. D. Prugh, 1985 .

Condensed Cyclobutane Aromatic Compounds. VI. The Pyrolysis of 1,3-Dihydroisothianaphthene-2,2-dioxide: A New Synthesis of Benzocyclobutene1

A. Deana, M. Cava, 1959 .

HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.

P. Darke, A. Deana, S. Graham, 1992, Journal of medicinal chemistry.

Methyl 3-0-benzyl-2,4,6-trideoxy-6-iodo-α-d--hexopyranoside, a chiral synthon for the synthesis of inhibitors of HMG-CoA reductase

A. Deana, J. D. Prugh, 1982 .

3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS. I. STRUCTURAL MODIFICATION OF 5-SUBSTITUTED 3,5-DIHYDROXYPENTANOIC ACIDS AND THEIR LACTONE DERIVATIVES

W. F. Hoffman, A. Deana, A. Alberts, 1985 .

The bacterial enzyme RppH triggers messenger RNA degradation by 5′ pyrophosphate removal

H. Čelešnik, J. Belasco, A. Deana, 2008, Nature.

Initiation of RNA decay in Escherichia coli by 5' pyrophosphate removal.

H. Čelešnik, J. Belasco, A. Deana, 2007, Molecular cell.

2-(AMINOMETHYL)PHENOLS, A NEW CLASS OF SALURETIC AGENTS. 3. EFFECTS OF FUNCTIONAL GROUP REORIENTATION AND MODIFICATION

A. Deana, Robert L. Smith, G. Stokker, 1982 .

Ribosome traffic in E. coli and regulation of gene expression.

R. Ehrlich, A. Deana, J Solomovici, 2000, Journal of theoretical biology.

Silent mutations in the Escherichia coli ompA leader peptide region strongly affect transcription and translation in vivo.

R. Ehrlich, A. Deana, C Reiss, 1998, Nucleic acids research.

Silent mutations affect in vivo protein folding in Escherichia coli.

Ricardo Ehrlich, Claude Reiss, R. Ehrlich, 2002, Biochemical and biophysical research communications.

Synonymous codon selection controls in vivo turnover and amount of mRNA in Escherichia coli bla and ompA genes

R. Ehrlich, A. Deana, C Reiss, 1996, Journal of bacteriology.

Consequences of RNase E scarcity in Escherichia coli

J. Belasco, A. Deana, Atilio Deana, 2002, Molecular microbiology.

High-level production of active human TFPI-2 Kunitz domain in plant.

A. Molina, A. Deana, P. Lunello, 2014, Protein expression and purification.

The function of RNase G in Escherichia coli is constrained by its amino and carboxyl termini

J. Belasco, A. Deana, 2004, Molecular microbiology.

Pseudopeptide inhibitors of Ras farnesyl-protein transferase.

N. Kohl, E. Rands, D. Pompliano, 1994, Journal of Medicinal Chemistry.

Pseudodipeptide inhibitors of protein farnesyltransferase.

N. Kohl, E. Rands, D. Pompliano, 1995, Journal of medicinal chemistry.

Differential Control of the Rate of 5′-End-Dependent mRNA Degradation in Escherichia coli

J. Belasco, Daniel J. Luciano, A. Deana, 2012, Journal of bacteriology.

PABLO analysis of RNA: 5'-phosphorylation state and 5'-end mapping.

H. Čelešnik, J. Belasco, A. Deana, 2008, Methods in enzymology.

Chapter 5 PABLO Analysis of RNA

H. Čelešnik, J. Belasco, A. Deana, 2008 .

Evidence-Based Policies in Uruguay Are Successful for Tackling COVID-19

A. Deana, L. Pittaluga, 2021 .

3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors. Part 3.

W. F. Hoffman, P. Anderson, J. Hirshfield, 1986 .